Variant report
Variant | esv3421475 |
---|---|
Chromosome Location | chr8:4917297-4921632 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564201633 | chr8:4917402-4917403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141695055 | chr8:4917445-4917446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17072168 | chr8:4917461-4917462 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs570304442 | chr8:4917502-4917503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567870153 | chr8:4917537-4917538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs80337800 | chr8:4917539-4917540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150524736 | chr8:4917540-4917541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528154414 | chr8:4917545-4917546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200897877 | chr8:4917559-4917560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566648322 | chr8:4917572-4917573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547856710 | chr8:4917583-4917584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201581229 | chr8:4917585-4917586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34454144 | chr8:4917587-4917588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184814749 | chr8:4917628-4917629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558945659 | chr8:4917630-4917631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571047598 | chr8:4917660-4917661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114776892 | chr8:4917663-4917664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17072170 | chr8:4917724-4917725 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs550898011 | chr8:4917734-4917735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139859229 | chr8:4917737-4917738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs5889084 | chr8:4917744-4917745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386721437 | chr8:4917750-4917751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200865696 | chr8:4917751-4917752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201974717 | chr8:4917752-4917753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201239946 | chr8:4917753-4917754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201507711 | chr8:4917754-4917755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs5889085 | chr8:4917761-4917762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528557819 | chr8:4917762-4917763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189215970 | chr8:4917796-4917797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200553969 | chr8:4917824-4917825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376799500 | chr8:4917855-4917856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144448630 | chr8:4917872-4917873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564146534 | chr8:4917886-4917887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531501381 | chr8:4917900-4917901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542858485 | chr8:4917911-4917912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1869521 | chr8:4917914-4917915 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs140198693 | chr8:4917929-4917930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181580031 | chr8:4917931-4917932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566612149 | chr8:4917943-4917944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75215286 | chr8:4917947-4917948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552285829 | chr8:4917958-4917959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570777279 | chr8:4917962-4917963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537861153 | chr8:4917972-4917973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556860982 | chr8:4917973-4917974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186532552 | chr8:4917991-4917992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547000007 | chr8:4918002-4918003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536033369 | chr8:4918005-4918006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554438428 | chr8:4918025-4918026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572036098 | chr8:4918036-4918037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552757726 | chr8:4918063-4918064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4917400-4918000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr8:4917400-4918600 | Enhancers | Brain Cingulate Gyrus | brain |
3 | chr8:4917600-4918200 | Enhancers | Brain Hippocampus Middle | brain |
4 | chr8:4917800-4918200 | Enhancers | Brain Anterior Caudate | brain |
5 | chr8:4918000-4918200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr8:4918000-4918200 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr8:4918000-4918600 | Enhancers | Esophagus | oesophagus |
8 | chr8:4918200-4920200 | Weak transcription | Brain Hippocampus Middle | brain |
9 | chr8:4920000-4920200 | Enhancers | Brain Anterior Caudate | brain |
10 | chr8:4920000-4920600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr8:4920200-4920600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr8:4920200-4920600 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr8:4920200-4920600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr8:4920200-4920600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr8:4920200-4920600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr8:4920200-4920600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr8:4920200-4920600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr8:4920200-4920600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr8:4920200-4920600 | Enhancers | Brain Hippocampus Middle | brain |
20 | chr8:4920200-4921400 | Enhancers | Fetal Lung | lung |
21 | chr8:4920400-4920600 | Enhancers | Brain Cingulate Gyrus | brain |
22 | chr8:4920400-4920600 | Enhancers | A549 | lung |